Evidence for immune activation against oxidized lipoproteins in inactive phases of juvenile chronic arthritis

Journal of Rheumatology

Volumn 28, Issue 1, 2001, Pages 198-203

  Simonini, G ^a   Cerinic, M M ^a   Cimaz, R ^a   Anichini, M ^a   Cesaretti, S ^a   Zoppi, M ^a   Generini, S ^a   Falcini, F ^a  

^a Department of Pediatrics ^*  (Italy)

Author keywords

Juvenile chronic arthritis; Low density lipoproteins; Oxidative stress

Indexed keywords

ALKADIENE; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ARTICLE; CONTROLLED STUDY; CROSS REACTION; DISEASE COURSE; FEMALE; HUMAN; IMMUNOSTIMULATION; JUVENILE RHEUMATOID ARTHRITIS; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, JUVENILE RHEUMATOID; BIOLOGICAL MARKERS; CHILD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LIPID PEROXIDATION; LIPID PEROXIDES; LIPOPROTEINS, LDL; MALE; MALONDIALDEHYDE; METHOTREXATE; OXIDATIVE STRESS;

EID: 0035167775     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Juvenile rheumatoid arthritis
2. Hypoxia, oxidative stress and rheumatoid arthritis
3. Protective factors against oxygen free radicals and hydrogen peroxide in rheumatoid arthritis synovial fluid
4. Lipid peroxidation in rheumatoid arthritis: Thiobarbituric acid-reactive material and catalytic iron salts in synovial fluid from rheumatoid patients
5. Hypoxic-reperfusion injury in the inflamed human joint
6. Pathophysiology of reperfusion injury in human joints
7. Oxidative damage to lipids within the inflamed human joint provides evidence of radical-mediated hypoxic-reperfusion injury
8. A study of the effect of rheumatoid synovial fluid on proliferation and IL-2 production by total mononuclear cells and purified CD4+ cells of synovial fluid and peripheral blood
9. Presence of foam cells containing oxidised low density lipoprotein in rheumatoid synovial membrane
10. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein
11. Oxygen radicals, nitric oxide and human inflammatory joint disease
12. Hydroxyl radical generation by rheumatoid blood and knee joint synovial fluid
13. Special meeting on nomenclature and classification of arthritis in children
14. Increased circulating nerve growth factor is directly correlated with disease activity in juvenile chronic arthritis
15. Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal
16. Continuous monitoring of in vitro oxidation of human low density lipoprotein
17. Antioxidised low density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers
18. Autoantibodies against oxidised LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus
19. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL
20. Crossreaction between antibodies to oxidised low-density lipoproteins and to cardiolipin in systemic lupus erythematosus
21. Binding profiles of cardiolipin-binding antibodies in SLE and infectious diseases
22. Lipid peroxidation: Its mechanism, measurement, and significance
23. Evidence for increased oxidative damage in patients with cystic fibrosis
24. Diabetes mellitus and free radicals
25. Kawasaki disease and oxidative metabolism
26. The effect of lipid peroxides and superoxide dismutase on SLE: A preliminary study
27. Autoantibodies against oxidatively modified low-density lipoprotein in patients with Bechet's disease
28. Increased lipid peroxidation in children with autoimmune diseases
29. Reactive oxygen species, lipid peroxides and essential fatty acids in patients with rheumatoid arthritis and systemic lupus erythematosus
30. Biochemical structural and functional properties of oxidised low-density lipoprotein
31. Effects of copper and histidine on oxidative modification of low density lipoprotein and its subsequent binding to collagen
32. Fibrous longspacing collagen in human atherosclerosis
33. Minimally modified low density lipoprotein stimulates monocyte endothelial cell interactions
34. Involvement of lipoproteins, free radicals, and calcium in cardiovascular disease processes
35. Serum antibodies to oxidised low density lipoprotein and ceroid in chronic periaortitis
36. Antibody against oxidised low-density lipoprotein predicting myocardial infarction
37. Autoantibody against oxidised LDL and progression of carotid atherosclerosis
38. Autoantibodies against oxidised low density lipoproteins in patients with coronary disease
39. Antibodies against oxidised low density lipoproteins in juvenile chronic arthritis
40. Autoantibodies against oxidized low density lipoproteins (oxLDL): Characterization of antibody isotype, subclass, affinity and effect on the macrophage uptake of ox LDL
41. Monoclonal antibodies against LDL further enhance macrophage uptake of LDL aggregates